Yoshimi A, Toya T, Nannya Y, Takaoka K, Kirito K, Ito E, Nakajima H, Hayashi Y, Takahashi T, Moriya-Saito A, Suzuki K, Harada H, Komatsu N, Usuki K, Ichikawa M, Kurokawa M. Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016;27(5):887-95.
Tsukune Y, Komatsu N. Management of Adult Chronic Immune Thrombocytopenia in Japan: Patient and Hematologist Perspectives from a Multi-center Cross-sectional Questionnaire Survey. Internal medicine (Tokyo, Japan). 2016;55(17):2379-85.
Tsukune Y, Sasaki M, Odajima T, Isoda A, Matsumoto M, Koike M, Tamura H, Moriya K, Ito S, Asahi M, Imai Y, Tanaka J, Handa H, Koiso H, Tanosaki S, Hua J, Hagihara M, Yahata Y, Suzuki S, Watanabe S, Sugimori H, Komatsu N. Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era. Annals of hematology. 2016;95(9):1465-72.
Miyasaka N, Miura O, Kawaguchi T, Arima N, Morishita E, Usuki K, Morita Y, Nishiwaki K, Ninomiya H, Gotoh A, Imashuku S, Urabe A, Shichishima T, Nishimura J, Kanakura Y. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review. International journal of hematology. 2016;103(6):703-12.
Mitsumori T, Komatsu N, Kirito K. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications. Internal medicine (Tokyo, Japan). 2016;55(4):405-7.
Matsuoka S, Ishii Y, Nakao A, Abe M, Ohtsuji N, Momose S, Jin H, Arase H, Sugimoto K, Nakauchi Y, Masutani H, Maeda M, Yagita H, Komatsu N, Hino O. Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation. PloS one. 2016;11(3):e0150496.
Kobayashi Y, Saita Y, Nishio H, Ikeda H, Takazawa Y, Nagao M, Takaku T, Komatsu N, Kaneko K. Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association. 2016;21(5):683-9.
Iizuka K, Yokomizo T, Watanabe N, Tanaka Y, Osato M, Takaku T, Komatsu N. Lack of Phenotypical and Morphological Evidences of Endothelial to Hematopoietic Transition in the Murine Embryonic Head during Hematopoietic Stem Cell Emergence. PloS one. 2016;11(5):e0156427.
Ichikawa K, Edahiro Y, Gotoh A, Iiduka K, Komatsu N, Koike M. Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia. International journal of hematology. 2016;104(5):612-20.
Baba T, Tanabe Y, Yoshikawa S, Yamanishi Y, Morishita S, Komatsu N, Karasuyama H, Hirao A, Mukaida N. MIP-1alpha/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice. Blood. 2016;127(21):2607-17.
Araki M, Yang Y, Masubuchi N, Hironaka Y, Takei H, Morishita S, Mizukami Y, Kan S, Shirane S, Edahiro Y, Sunami Y, Ohsaka A, Komatsu N. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood. 2016;127(10):1307-16.
Yasuda H, Tsutsui M, Ota Y, Misawa K, Gotoh A, Hamano Y, Komatsu N. Blastic plasmacytoid dendritic cell neoplasm accompanied by autoimmune hemolytic anemia achieving complete remission with hydroxyurea and steroids. Geriatrics & gerontology international. 2016;16(3):396-8.
Tsukune Y, Sasaki M, Odajima T, Isoda A, Matsumoto M, Koike M, Tamura H, Moriya K, Ito S, Asahi M, Imai Y, Tanaka J, Handa H, Koiso H, Tanosaki S, Hua J, Hagihara M, Yahata Y, Suzuki S, Watanabe S, Sugimori H, Komatsu N. Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era. Annals of hematology. 2016;95(9):1465-72.
Sunami Y, Ichikawa K, Edahiro Y, Komatsu N, Koike M. Safe and effective induction therapy with CHASER for primary testicular lymphoma with central nervous system involvement. Int J Clin Exp Med. 2016;9(9):18645-9.
Sekiguchi Y, Shirane S, Takizawa H, Wakabayashi M, Sugimoto KJ, Tomita S, Izumi H, Nakamura N, Sawada T, Ohta Y, Komatsu N, Noguchi M. T-cell lymphoma complicated by myelofibrosis: report of three cases and review of literature. Int J Clin Exp Pathol. 2016;9(8):7836-53.
Sekiguchi Y, Ichikawa K, Takizawa H, Wakabayashi M, Sugimoto K, Tomita S, Izumi H, Nakamura N, Sawada T, Hirai T, Sekikawa I, Ohta Y, Komatsu N, Noguchi M. Epstein-Barr virus-negative and CD56-positive primary central nervous system lymphoproliferative disorder (diffuse large B-cell lymphoma): a case of report and review of the literature. Int J Clin Exp Pathol. 2016;9(8):8017-26.
Sekiguchi Y, Inano T, Fukuda Y, Takizawa H, Wakabayashi M, Sugimoto KJ, Tomita S, Izumi H, Nakamura N, Sawada T, Ohta Y, Komatsu N, Noguchi M. A long-term favorable response and effective control of neutropenia obtained by low-dose pomalidomide treatment in a patient with relapsed refractory multiple myeloma: a case report. Int J Clin Exp Med. 2016;9(11):22561-9.
Nakamura R, Ueno Y, Ando J, Matsuda H, Masuda A, Iiduka K, Shingai N, Takanashi M, Yokoyama K, Komatsu N, Hattori N. Clinical and radiological CLIPPERS features after complete remission of peripheral T-cell lymphoma, not otherwise specified. Journal of the neurological sciences. 2016;364:6-8.
Mitsumori T, Komatsu N, Kirito K. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications. Internal medicine (Tokyo, Japan). 2016;55(4):405-7.
Mohammad S, Gotoh A, Morishita S, Komatsu N. Imatinib-sensitive myeloid neoplasm with low allele burden of FIP1L1-PDGFRA fusion gene in an elderly patient. Geriatrics & gerontology international. 2016;16(12):1346-8.
Edahiro Y, Ichikawa K, Suzuki H, Yasuda H, Koike M, Komatsu N. Successful perioperative management of factor XI deficiency with administration of fresh-frozen plasma in a subdural hematoma patient. Geriatrics & gerontology international. 2016;16(1):143-4.
和文症例報告
Sunami Y, Gotoh A, Watanabe N, Edahiro Y, Hamano Y, Harada H, Komatsu N. [Chronic Myelomonocytic Leukemia with Myelofibrosis Resulting in Sudden Massive Pleural Effusion during Cytoreductive Therapy with Hydroxycarbamide]. Gan to kagaku ryoho Cancer & chemotherapy. 2016;43(10):1223-6.
Ando J, Masuda A, Iizuka K, Ochiai T, Takaku T, Osawa T, Shimada E, Watanabe Y, Komatsu N, Osaka A. Congenital haptoglobin deficiency discovered on the occasion of anaphylaxis induced by platelet concentrate transfusion. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2016;57(12):2507-11.
Araki M, Yang Y, Masubuchi N, Hironaka Y, Takei H, Morishita S, Mizukami Y, Kan S, Shirane S, Edahiro Y, Sunami Y, Ohsaka A, Komatsu N. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms ,21st EHA Congress, Copenhagen, Denmark, June 9-12, 2016.
Iriyama N, Takaku T, Sato E, Ishikawa M, Nakazato T, Sugimoto KJ, Fujita H, Tokuhira M, Kawaguchi T. Clinical Entity and Outcomes of Therapy-Related Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: Surveillance By the Chronic Myeloid Leukemia Cooperative Study Group, 58th ASH Annual Meeting and Exposition, San Diego, USA, December 3-6, 2016.
Nishiwaki K, Sugimoto KJ, Tamaki S, Hisatake J, Yokoyama H, Igarashi T, Shinagawa A, Sugawara T, Hara S, Fujikawa K, Shimizu S, Toshiaki Y, Tojo A, Wakita H. Optimal Treatment Strategy with Nilotinib for Patients with Newly Diagnosed Chronic Myelogenous Leukemia in the Chronic Phase Based on Early Achievement of Deep Molecular Response (MR4.5) : First Report from N-Road, a Phase II Study in Japan., 58th ASH Annual Meeting and Exposition, San Diego, USA, December 3-6, 2016.
Isobe Y, Masuda A, Sugimoto K, Komatsu N. The Long Form of Cellular FLIP Renders NK-Cell Lymphoma Cells Resistant to Fas-Mediated Apoptosis, 58th ASH Annual Meeting and Exposition, San Diego, USA, December 3-6, 2016.
池之内穣, 関口康宣, 杉元啓二, 若林睦, 瀧澤春子, 小松則夫, 野口雅章: BMではなくリンパ節と漿膜におけるIgAκ+ CD20+ CD19-形質細胞腫の典型的な1症例(A typical case of IgA kappa+ CD20+ CD19-plasmacytoma not in BM but in lymph node and serosa, 第56回日本リンパ網内系学会総会; ホテル日航熊本 2016年9月3日.
Okuda Y, Aota Y, Yokoyama T, Kitagawa N, Shinozawa K, Amano K, Fukutake K, Gotoh A, Komatsu N. Anticagulant therapy for a vein thrombosis Caucasian patient with the Factor V Leiden mutation. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Ochiai T, Araki M, Misawa K, Morishita S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y, Sunami Y Gotoh A, Ohsaka A, Komatsu N. Clinical characteristics of BCSH criteria defined PV and ET patients in Japan. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Tsutsui M, Gotoh A, Araki M, Morishita S, Komatsu N. Impact of mutations on efficacy of anagrelide in Japanese patients with essential thrombocythemia. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Misawa K, Araki M, Ochiai T, Morishita S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y, Sunami Y, Gotoha A, Ohsaka A, Komatsu N. Differential clinical features by sbtypes of Calreticulin mutation in myeloproliferative neoplasms. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Fujioka I, Takaku T, Watanabe N, Gotoh A, Komatsu N. Assessment of treatment response by international scale in Japanese patients with chronic phase CML. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Iizuka K, Andou J, Ochiai T, Shirane S, Masuda A, Gotoh A, Koike M, Komatsu N. Efficacy of GDP for anti-L-asparaginase antibody positive and /or SMILE resistant NK/T lymphpma. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Soeda S, Tamura H, Ishibashi M, Sasaki M, Handa H, Imai Y, Tanosaki S, Isoda A, Matsumoto M, Ito S, Koike M, Komatsu N, Inokuchi K. The impact of serum soluble SLAMF7 on myeloma pathogenesis and anti-SLAMF7 antibody-based therapy. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Tsubota A, Tamura H, Ishibashi M, Sasaki M, Handa H, Imai Y, Tanosaki S, Isoda A, Matsumoto M, Ito S, Koike M, Komastu N, Inokuchi K. Clinical significance of serum soluble and plasma cell-surface SLAMF3 levels in multiple myeloma. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Moriya K, Ishibashi M, Tamura H, Handa H, Sasaki M, Isoda A, Imai Y, Ito S, Tanosaki S, Inokuchi K, Komastu N, Matsumoto M, Tanaka J, Koike M. Clinical significance of IL-6 and IGF-1 receptor expression on myeloma cells. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Yamada A, Tamura H, Ishibashi M, Sasaki M, Komastu N, Handa H, Imai Y, Tanosaki S, Ito S, Isoda A, Matsumoto M, Koike M, Inokuchi K. An aggressive myeloma patient with high KL-6 production and clinical impact of serum KL-6 in myeloma. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Sugimoto K, Suzuki H, Fujimura T, Ono A, Kaga N, Isobe Y, Sasaki M, Taka H, Miyazono K, Komatsu N. Association of glutaminase high expression with L-asparaginase-sensitivity in lymphoid leukemia cells. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
瀧澤春子, 関口康宜, 若林睦, 杉元啓二, 小松則夫, 野口雅章: A Case of AE Free Remission of RRMM in Response to FVD during Maintenance Hemodialysis. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
小池道明, 飯塚和秀, 重光文子, 白根脩一, 小松則夫: Efficacy of cyclosporin A therapy for three cases of angioimmunoblastic T cell lymphoma (AITL), 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
佐藤恵理子, 野口雅章, 小池道明, 森下総司, 大津洋, 小松則夫: Stop trial against CMP-CP in CMR patients who had received sequential TKIs; an interim analysis. , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日
Masubuchi N, Araki M, Yang Y, Hironaka Y, Takei H, Morishita S, Mizukami Y, Kan S, Ohsaka A, Komatsu N. Cell surface localization of mutant calreticulin that induces myeloproliferative neoplasms (MPNs). , 第78回日本血液学会学術集会; パシフィコ横浜 2016年10月13-15日